MolecuLight All-in-One Oxygenation Clinical Utility

NCT07646938 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2026-07-02

No results posted yet for this study

Summary

This is a prospective, clinical evaluation of the MolecuLightDX+ with OxySight Module in wound care.

Conditions

  • Wounds

Interventions

DEVICE

MolecuLightDX+ with OxySight Module

MolecuLightDX+ with OxySight Module is an imaging device intended to acquire fluorescence, oxygenation, thermal, and measurement images of wounds.

Sponsors & Collaborators

  • MolecuLight Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-25
Primary Completion
2026-03-27
Completion
2026-03-27
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07646938 on ClinicalTrials.gov